Post-authorization Safety Study Evaluation of Cardiovascular Events in Users of Mirabegron and Other Treatments for Overactive Bladder

First published 30/11/2016

Last updated 02/07/2024

EU PAS number:

EUPAS16282

Study

Finalised

Documents

Study protocol

Initial protocol

178-CL-114_Protocol Version 9.0_For EnCepp Reg

English (1.17 MB - PDF) View document

Updated protocol

178-cl-114-clp-10-reissue-v11-en-final-02

First published: 22/02/2024

English (2.09 MB - PDF) View document

Study results

178-cl-114-clgr-disc01-en-final-02

English (745.17 KB - PDF) View document

Study report

Other information

Secondary tabs